Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
---|
07/06/2006 | WO2006070349A2 Novel process for preparing pramipexole and its optical isomeric mixture by reduction with sodium triacetoxyborohydride |
07/06/2006 | WO2006069656A1 Fused bicyclic carboxamide derivatives for use as cxcr2 inhibitors in the treatment of inflammation |
07/06/2006 | WO2006017215A3 Histone deacetylase inhibitors |
07/06/2006 | WO2005116002A3 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
07/06/2006 | US20060149091 Method for producing difluoro-acetyl-acetic acid alkylesters |
07/06/2006 | US20060149075 Crystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione |
07/06/2006 | US20060148866 Novel process for preparing pramipexole and its optical isomeric mixture by reduction with sodium triacetoxyborohydride |
07/06/2006 | US20060148862 Novel compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof |
07/06/2006 | US20060148822 5-Phenylthiazole derivatives and their use as p13 kinase inhibitors |
07/06/2006 | US20060148043 Novel optically active, heteroaromatic beta-hydroxy esters and processes for their preparation from beta-keto esters and processes for the preparation of these beta-keto esters |
07/06/2006 | US20060148042 Biotransformation to produce stereospecific drug; reacting a substituted arylaldehydes and 2-oxoacids using 2-hydroxy-3-oxoacid synthases; bacterial origin, yeast enzyme, Escherichia coli, fungal enzyme, and plant; pure enantiomers (R)-phenylacetyl carbinol |
07/06/2006 | US20060147525 Lipophilic drug compositions |
07/06/2006 | CA2592430A1 Fused bicyclic carboxamide derivatives for use as cxcr2 inhibitors in the treatment of inflammation |
07/05/2006 | EP1676834A1 Fused bicyclic carboxamide derivates for use as CXCR2 inhibitors in the treatment of inflammation |
07/05/2006 | EP1675844A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase |
07/05/2006 | EP1675836A1 Derivatives of 4-phenylthiazoles and 4-phenylimidazoles and the use thereof as medicaments for treating neurodegenerative diseases, pain and epilepsy |
07/05/2006 | CN1798743A N-alkynyl-2-heteroaryloxyalkylamides for use as fungicides |
07/05/2006 | CN1798733A Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease |
07/05/2006 | CN1798558A Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine a2a receptor |
07/05/2006 | CN1262547C Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative |
07/05/2006 | CN1262540C Bicycle androgen and progesterone receptor modulator compounds and methods |
07/04/2006 | US7071358 Lipid diseases; metabolism diosrders; antiproliferative agents |
07/04/2006 | US7071221 Heterocyclic oxime compounds |
07/04/2006 | US7071220 Chymase inhibitor; cardiovascular disorders, circulation diseases; hypotensive agents |
07/04/2006 | US7071218 N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases |
07/04/2006 | US7071212 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
07/04/2006 | US7071191 Non-imidazole aryloxypiperidines |
07/04/2006 | US7071177 P-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents |
07/04/2006 | US7071175 Pyridine mercapto carboxylic acids as carboxypeptidase U inhibitors |
07/04/2006 | US7070625 Agent and method for coloring keratin fibers containing 2-benzothiazolinone-hydrazone and quinone derivatives |
07/04/2006 | CA2250840C Antivirally active heterocyclic azahexane derivatives |
07/04/2006 | CA2130797C 2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity, and synthesis of .alpha.-substituted-arylacetamides |
06/29/2006 | WO2006068593A1 New benzothiazolesulfonamides |
06/29/2006 | WO2006068592A1 New benzothiazolecarboxamides |
06/29/2006 | WO2006067472A1 Parp inhibitors |
06/29/2006 | WO2006067086A1 New 3-phenylpropionic acid derivatives for the treatment of diabetes |
06/29/2006 | WO2006066779A1 Novel cyclohexane derivatives |
06/29/2006 | WO2006066747A1 4-aminopiperidine derivatives |
06/29/2006 | WO2006028269A3 Thiazole derivatives having vap-1 ihibitory activity |
06/29/2006 | US20060142586 Synthesis of 2-alkyl amino acids |
06/29/2006 | US20060142585 Novel dipeptidyl peptidase IV inhibitors pharmaceutical compositions containing them, and process for their preparation |
06/29/2006 | US20060142584 Epothilone side components |
06/29/2006 | US20060142357 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
06/29/2006 | US20060142325 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
06/29/2006 | US20060142296 4(Phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
06/29/2006 | US20060141043 Aqueous dispersion comprising stable nanoparticles of a water-insoluble thiazole derivative and excipients like middle chain triglycerides |
06/29/2006 | DE102004061503A1 New meta-substituted thiazolidinone compounds are polo-like kinase inhibitors useful to treat cancers, autoimmune-, cardiovascular-, infectious-, nephrological-, nephrological- and neurodegenerative-diseases |
06/29/2006 | DE102004060247A1 New N-heterocyclic carbene radical compounds useful as e.g. catalysts in organocatalysis; and ligands in transition metal catalysts in homogeneous catalysis |
06/29/2006 | DE10102084B4 1,4-Diamino-2-(thiazol-2-yl)-benzol-Derivate enthaltende Haarfärbemittel 1,4-diamino-2- (thiazol-2-yl) benzene derivatives containing hair dye |
06/29/2006 | CA2591117A1 Novel heteroarylacetamides |
06/29/2006 | CA2590957A1 4-aminopiperidine derivatives |
06/28/2006 | EP1674097A1 Compounds effecting glucokinase |
06/28/2006 | EP1674096A2 Hypoglycemics comprising organic zinc (II) complexes |
06/28/2006 | EP1673357A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
06/28/2006 | EP1673356A1 Substituted benzylaminoalkylene heterocycles |
06/28/2006 | EP1673353A1 Transition state structure and inhibitors of thymidine phosphorylases |
06/28/2006 | EP1673342A2 Amides that inhibit vanilloid receprot subtype 1 (vr1) receptor |
06/28/2006 | EP1673336A1 Cathepsin cysteine protease inhibitors |
06/28/2006 | EP1562920B1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
06/28/2006 | EP1544201B1 Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications |
06/28/2006 | CN1795178A Process for synthesizing heterocyclic compounds |
06/28/2006 | CN1795175A Acetylene derivatives as inhibitors of histone deacetylase |
06/28/2006 | CN1794989A N-(((((1,3-thiazol-2-yl)amino)carbonyl)phenyl)sulfonyl)phenylalanine derivatives and related compounds for the treatment of diabetes |
06/28/2006 | CN1261420C Process for the manufacture of thiazole derivatives with pesticide activity |
06/28/2006 | CN1261098C p38-alpha kinase inhibitors |
06/27/2006 | US7067675 reduction of the ketone group of 3-[5-(4-fluorophenyl)-1,5-dioxopentyl]-4-alkyl- or phenyl-2-oxa- or thiazolidin-one, -thione or -alkylimine with (-)-DIP chloride to obtain the corresponding 5-hydroxy- derivative |
06/27/2006 | US7067674 m-[(7-benzothiazol-2-yl-9,9-dialkylfluoren-2-yl)phenylamino]phenoxyalkyl methacrylate or m-[(7-benzothiazol-2-yl-9,9-dialkylfluoren-2-yl)phenylamino]phenyl p-vinylbenzyl ether; |
06/27/2006 | US7067553 Thiourea compounds and the pharmaceutical compositions containing the same |
06/27/2006 | US7067544 a high purity epothilone from Sorangium cellulosum; anticarcinogenic, antitumor agents |
06/27/2006 | US7067542 Diaminediols for the treatment of Alzheimer's disease |
06/27/2006 | US7067538 monocyte chemoattractant protein-1; a bis(phenyl) sulfonyl or sulfonamido ketone or dihydroxy compound; antiinflammatory, anticholesterol, antiarthritic agents; immunotherapy; transplant rejection |
06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
06/27/2006 | US7067516 Compounds used as antiinflammatory agents and enzyme inhibitors |
06/27/2006 | US7067506 Compounds useful for inhibiting Chk1 |
06/27/2006 | US7067286 Cystobacterineae host cells containing heterologous PKS genes for the synthesis of polykedtides |
06/27/2006 | CA2238633C Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors |
06/22/2006 | WO2006066173A2 Novel mch receptor antagonists |
06/22/2006 | WO2006066126A2 Phenol-heterocyclic ligands, metal complexes, and their uses as catalysts |
06/22/2006 | WO2006064246A1 N- (2-aminophenyl) -4- (5- ((ethylamino) methyl) 1,3-thiazol-2-yl) benzamide and n- (2-aminopheynl) -4- (5- ((isopropylamino) methyl) -1,3-thiazol-2-yl) benzamide as hdac inhibitors |
06/22/2006 | WO2006063999A1 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
06/22/2006 | WO2006063806A1 Meta-substituted thiazolidinones, the production thereof and their use as medicaments |
06/22/2006 | WO2003061655A8 2-aminothiazole allosteric enhancers of a1 adenosine receptors |
06/22/2006 | US20060135782 Benzazole analogues and uses thereof |
06/22/2006 | US20060135781 Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses thereof |
06/22/2006 | US20060135770 PARP inhibitors |
06/22/2006 | US20060135576 2-Amino-(imidazole, thiazole, or oxazole) derivatives; tyrosine kinase, endothelial growth factor, angiogenesis and fibroblast growth factor inhibitors; anticarcinogenic and antidiabetic agents |
06/22/2006 | US20060135575 2-Acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof |
06/22/2006 | US20060135573 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
06/22/2006 | US20060135572 Compounds as for example, 2'-[1-[(2R)-3-[[1-(3-fluoro-4-methylphenyl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]ethyl]-3-methylbiphenyl-4-carboxylic acid, having a calcium-sensing receptor antagonistic action; therapeutic drug for osteoporosis |
06/22/2006 | US20060135503 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; N-[2-[[(cis) -2-[[1- (4-Chlorophenyl)ethyl]amino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide |
06/22/2006 | CA2590932A1 Thiazolium compounds and uses thereof |
06/22/2006 | CA2590396A1 Meta-substituted thiazolidinones, their production and use as pharmaceutical agents |
06/22/2006 | CA2589678A1 Novel mch receptor antagonists |
06/22/2006 | CA2589495A1 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
06/21/2006 | EP1671969A2 Thiazolyl inhibitors of tec family tyrosine kinases |
06/21/2006 | EP1670778A1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics |
06/21/2006 | EP1670775A1 Piperazine subtituted compounds used as calcium channel blockers |
06/21/2006 | EP1670772A1 Derivatives of 1,3-diones having a herbicidal activity |
06/21/2006 | EP1670458A1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics |
06/21/2006 | EP1450797B1 Benzothiazole derivatives |